1dfh: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="1dfh" size="450" color="white" frame="true" align="right" spinBox="true" caption="1dfh, resolution 2.2Å" /> '''X-RAY STRUCTURE OF ES...
 
No edit summary
Line 1: Line 1:
[[Image:1dfh.jpg|left|200px]]<br /><applet load="1dfh" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1dfh.jpg|left|200px]]<br /><applet load="1dfh" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1dfh, resolution 2.2&Aring;" />
caption="1dfh, resolution 2.2&Aring;" />
'''X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE'''<br />
'''X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE'''<br />


==Overview==
==Overview==
Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is, the target for antibacterial diazaborines and the front-line, antituberculosis drug isoniazid. Analysis of the structures of complexes, of Escherichia coli ENR with nicotinamide adenine dinucleotide and either, thienodiazaborine or benzodiazaborine revealed the formation of a covalent, bond between the 2' hydroxyl of the nicotinamide ribose and a boron atom, in the drugs to generate a tight, noncovalently bound bisubstrate analog., This analysis has implications for the structure-based design of, inhibitors of ENR, and similarities to other oxidoreductases suggest that, mimicking this molecular linkage may have generic applications in other, areas of medicinal chemistry.
Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is the target for antibacterial diazaborines and the front-line antituberculosis drug isoniazid. Analysis of the structures of complexes of Escherichia coli ENR with nicotinamide adenine dinucleotide and either thienodiazaborine or benzodiazaborine revealed the formation of a covalent bond between the 2' hydroxyl of the nicotinamide ribose and a boron atom in the drugs to generate a tight, noncovalently bound bisubstrate analog. This analysis has implications for the structure-based design of inhibitors of ENR, and similarities to other oxidoreductases suggest that mimicking this molecular linkage may have generic applications in other areas of medicinal chemistry.


==About this Structure==
==About this Structure==
1DFH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with NAD and TDB as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1DFH OCA].  
1DFH is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Escherichia_coli Escherichia coli] with <scene name='pdbligand=NAD:'>NAD</scene> and <scene name='pdbligand=TDB:'>TDB</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Enoyl-[acyl-carrier-protein]_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.3.1.9 1.3.1.9] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1DFH OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Baldock, C.]]
[[Category: Baldock, C.]]
[[Category: Rafferty, J.B.]]
[[Category: Rafferty, J B.]]
[[Category: Rice, D.W.]]
[[Category: Rice, D W.]]
[[Category: NAD]]
[[Category: NAD]]
[[Category: TDB]]
[[Category: TDB]]
Line 23: Line 23:
[[Category: oxidoreductase]]
[[Category: oxidoreductase]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 13:14:32 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 12:16:06 2008''

Revision as of 13:16, 21 February 2008

File:1dfh.jpg


1dfh, resolution 2.2Å

Drag the structure with the mouse to rotate

X-RAY STRUCTURE OF ESCHERICHIA COLI ENOYL REDUCTASE WITH BOUND NAD AND THIENO-DIAZABORINE

OverviewOverview

Enoyl reductase (ENR), an enzyme involved in fatty acid biosynthesis, is the target for antibacterial diazaborines and the front-line antituberculosis drug isoniazid. Analysis of the structures of complexes of Escherichia coli ENR with nicotinamide adenine dinucleotide and either thienodiazaborine or benzodiazaborine revealed the formation of a covalent bond between the 2' hydroxyl of the nicotinamide ribose and a boron atom in the drugs to generate a tight, noncovalently bound bisubstrate analog. This analysis has implications for the structure-based design of inhibitors of ENR, and similarities to other oxidoreductases suggest that mimicking this molecular linkage may have generic applications in other areas of medicinal chemistry.

About this StructureAbout this Structure

1DFH is a Single protein structure of sequence from Escherichia coli with and as ligands. Active as [acyl-carrier-protein_reductase_(NADH) Enoyl-[acyl-carrier-protein] reductase (NADH)], with EC number 1.3.1.9 Full crystallographic information is available from OCA.

ReferenceReference

A mechanism of drug action revealed by structural studies of enoyl reductase., Baldock C, Rafferty JB, Sedelnikova SE, Baker PJ, Stuitje AR, Slabas AR, Hawkes TR, Rice DW, Science. 1996 Dec 20;274(5295):2107-10. PMID:8953047 [[Category: Enoyl-[acyl-carrier-protein] reductase (NADH)]]

Page seeded by OCA on Thu Feb 21 12:16:06 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA